Cargando…

Nonirritant concentrations for skin testing with SARS-CoV-2 mRNA vaccine

Detalles Bibliográficos
Autores principales:	Marcelino, João, Farinha, Sofia, Silva, Rita, Didenko, Irina, Proença, Miguel, Tomáz, Elza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Clinical Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985655/ https://www.ncbi.nlm.nih.gov/pubmed/33766582 http://dx.doi.org/10.1016/j.jaip.2021.03.022

Ejemplares similares

Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000
por: Vieira, João, et al.
Publicado: (2021)

Nonirritating skin test concentrations for ceftazidime and aztreonam in patients with a documented beta-lactam allergy
por: van der Poorten, Marie-Line M., et al.
Publicado: (2021)

Nonirritant concentrations and amount of active ingredient in drug patch tests optimal concentrations for DPTs
por: Brajon, Delphine, et al.
Publicado: (2014)

Nonirritant and Cytocompatible Tinospora cordifolia Nanoparticles for Topical Antioxidant Treatments
por: González-Masís, Jeimmy, et al.
Publicado: (2020)

Stevens-Johnson syndrome related with Comirnaty® coronavirus disease 2019 vaccine
por: Marcelino, João, et al.
Publicado: (2022)

Late-Onset Rash from Irbesartan: An Immunological Reaction
por: Cardoso, Bárbara Kong, et al.
Publicado: (2019)

The effect of SARS-CoV-2 mRNA vaccination on AMH concentrations in infertile women
por: Horowitz, Eran, et al.
Publicado: (2022)

Therapeutic Effect of mRNA SARS-CoV-2 Vaccine on Melanoma Skin Metastases
por: Bafaloukos, Dimitrios, et al.
Publicado: (2022)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
por: Jackson, Lisa A., et al.
Publicado: (2020)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021)

Serological response to a single dose of a SARS-CoV-2 mRNA vaccine
por: Ramos, Angélica, et al.
Publicado: (2021)

SARS-CoV-2 Nsp1 mediated mRNA degradation requires mRNA interaction with the ribosome
por: Shehata, Soraya I., et al.
Publicado: (2023)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

B-Cell Responses to Sars-Cov-2 mRNA Vaccines
por: Kardava, Lela, et al.
Publicado: (2022)

Collagenous colitis following SARS‐Cov2 mRNA vaccination
por: Iketani, Momoko, et al.
Publicado: (2023)

Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines
por: Nappi, Emanuele, et al.
Publicado: (2023)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
por: Anderson, Evan J., et al.
Publicado: (2020)

SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
por: Anderson, Elizabeth M., et al.
Publicado: (2022)

Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction
por: Hoff, Norman-Philipp, et al.
Publicado: (2021)

SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block
por: Burke, James M., et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

Integrity and Stability of PTC Bearing CFTR mRNA and Relevance to Future Modulator Therapies in Cystic Fibrosis
por: Clarke, Luka A., et al.
Publicado: (2021)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
por: Bettini, Emily, et al.
Publicado: (2021)

Ramsay Hunt syndrome following mRNA SARS-COV-2 vaccine()
por: Rodríguez-Martín, Minerva, et al.
Publicado: (2022)

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
por: Ali, Kashif, et al.
Publicado: (2021)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Immediate reactions after mRNA SARS-CoV-2 vaccination
por: Jeimy, Samira, et al.
Publicado: (2021)

Note for “Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination”()
por: Rodríguez-Martín, Minerva
Publicado: (2022)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5uk1q4orsb6nb978nvl3h0hsu7